Randomised, double blind, placebo controlled, parallel group, 12 month trial of Leuco-methylthioninium bis(hydromethanesulfonate) in subjects with mild to moderate Alzheimer’s Disease.
Randomised, double blind, placebo controlled, parallel group, 12 month trial of Leuco-methylthioninium bis(hydromethanesulfonate) in subjects with mild to moderate Alzheimer’s Disease.